BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31696423)

  • 1. Systematic analysis of global health research funding in Canada, 2000-2016.
    Hoffman SJ; Gunn E; Rogers Van Katwyk S; Nixon S
    Can J Public Health; 2020 Feb; 111(1):80-95. PubMed ID: 31696423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involving citizens and patients in health research.
    Venuta R; Graham ID
    J Ambul Care Manage; 2010; 33(3):215-22. PubMed ID: 20539148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a rapid environmental scan methodology to map country-level global health research expertise in Canada.
    Nagi R; Rogers Van Katwyk S; Hoffman SJ
    Health Res Policy Syst; 2020 Apr; 18(1):37. PubMed ID: 32272941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confined to a tokenistic status: Social scientists in leadership roles in a national health research funding agency.
    Albert M; Laberge S
    Soc Sci Med; 2017 Jul; 185():137-146. PubMed ID: 28578211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Institutes of Health Research funding of prison health research: a descriptive study.
    Kouyoumdjian FG; McIsaac KE; Foran JE; Matheson FI
    CMAJ Open; 2017; 5(1):E14-E18. PubMed ID: 28401113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis.
    Head MG; Goss S; Gelister Y; Alegana V; Brown RJ; Clarke SC; Fitchett JRA; Atun R; Scott JAG; Newell ML; Padmadas SS; Tatem AJ
    Lancet Glob Health; 2017 Aug; 5(8):e772-e781. PubMed ID: 28668230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we moving the dial? Canadian health research funding trends for women's health, 2S/LGBTQ + health, sex, or gender considerations.
    Stranges TN; Namchuk AB; Splinter TFL; Moore KN; Galea LAM
    Biol Sex Differ; 2023 Jun; 14(1):40. PubMed ID: 37322516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening.
    Bowser D; Sparkes SP; Mitchell A; Bossert TJ; Bärnighausen T; Gedik G; Atun R
    Health Policy Plan; 2014 Dec; 29(8):986-97. PubMed ID: 24197405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resource allocation for biomedical research: analysis of investments by major funders.
    Ralaidovy AH; Adam T; Boucher P
    Health Res Policy Syst; 2020 Feb; 18(1):20. PubMed ID: 32066463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equity at all cost-and any price-for research funding in Canada?
    Guichard A; Ridde V
    Can J Public Health; 2019 Feb; 110(1):114-117. PubMed ID: 30232717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting equitable global health research: a policy analysis of the Canadian funding landscape.
    Plamondon K; Walters D; Campbell S; Hatfield J
    Health Res Policy Syst; 2017 Aug; 15(1):72. PubMed ID: 28851388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013.
    Head MG; Fitchett JR; Nageshwaran V; Kumari N; Hayward A; Atun R
    EBioMedicine; 2016 Jan; 3():180-190. PubMed ID: 26870829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010.
    Fitchett JR; Head MG; Cooke MK; Wurie FB; Atun R
    PLoS One; 2014; 9(8):e105722. PubMed ID: 25162631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments.
    McIntosh SA; Alam F; Adams L; Boon IS; Callaghan J; Conti I; Copson E; Carson V; Davidson M; Fitzgerald H; Gautam A; Jones CM; Kargbo S; Lakshmipathy G; Maguire H; McFerran K; Mirandari A; Moore N; Moore R; Murray A; Newman L; Robinson SD; Segaran A; Soong CN; Walker A; Wijayaweera K; Atun R; Cutress RI; Head MG
    Lancet Oncol; 2023 Jun; 24(6):636-645. PubMed ID: 37269844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious disease research investments follow colonial ties: questionable ethics.
    Fitchett JR; Head MG; Atun R
    Int Health; 2014 Mar; 6(1):74-6. PubMed ID: 24464047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icing or cake? Grant competitions as a model for funding chronic disease prevention in Tasmania, Australia.
    Loblay V; Garvey K; Shiell A; Kavanagh S; Hawe P
    Health Promot Int; 2022 Oct; 37(5):. PubMed ID: 36166260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
    Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
    Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in National Institutes of Health Funding of Principal Investigators in Dermatology Research by Academic Degree and Sex.
    Cheng MY; Sukhov A; Sultani H; Kim K; Maverakis E
    JAMA Dermatol; 2016 Aug; 152(8):883-8. PubMed ID: 27191545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canada's international response to HIV during times of global transition: a qualitative inquiry.
    Nixon S
    Curr HIV Res; 2011 Apr; 9(3):194-201. PubMed ID: 21457132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
    Head MG; Brown RJ; Newell ML; Scott JAG; Batchelor J; Atun R
    Lancet Glob Health; 2020 Oct; 8(10):e1295-e1304. PubMed ID: 32971052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.